These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22067001)

  • 1. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
    Kimura K; Kitaura H; Fujii T; Hakami ZW; Takano-Yamamoto T
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):219-27. PubMed ID: 22067001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model.
    Kimura K; Kitaura H; Fujii T; Ishida M; Hakami ZW; Takano-Yamamoto T
    Oral Dis; 2014 Apr; 20(3):319-24. PubMed ID: 23651419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M-CSF mediates TNF-induced inflammatory osteolysis.
    Kitaura H; Zhou P; Kim HJ; Novack DV; Ross FP; Teitelbaum SL
    J Clin Invest; 2005 Dec; 115(12):3418-27. PubMed ID: 16294221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo.
    Yoshimatsu M; Kitaura H; Fujimura Y; Eguchi T; Kohara H; Morita Y; Yoshida N
    Bone; 2009 Nov; 45(5):1010-6. PubMed ID: 19651258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
    Ishida M; Kitaura H; Kimura K; Sugisawa H; Aonuma T; Takada H; Takano-Yamamoto T
    J Immunol Res; 2015; 2015():132765. PubMed ID: 26000311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
    Lee K; Kim MY; Ahn H; Kim HS; Shin HI; Jeong D
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti-c-Fms antibody inhibits orthodontic tooth movement.
    Kitaura H; Yoshimatsu M; Fujimura Y; Eguchi T; Kohara H; Yamaguchi A; Yoshida N
    J Dent Res; 2008 Apr; 87(4):396-400. PubMed ID: 18362327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
    Ohno H; Kubo K; Murooka H; Kobayashi Y; Nishitoba T; Shibuya M; Yoneda T; Isoe T
    Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
    J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
    Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors.
    Strålberg F; Kassem A; Kasprzykowski F; Abrahamson M; Grubb A; Lindholm C; Lerner UH
    J Leukoc Biol; 2017 May; 101(5):1233-1243. PubMed ID: 28196851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation.
    Ayon Haro ER; Ukai T; Yokoyama M; Kishimoto T; Yoshinaga Y; Hara Y
    J Periodontal Res; 2011 Jun; 46(3):361-73. PubMed ID: 21361961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.
    Hayashi S; Tsuneto M; Yamada T; Nose M; Yoshino M; Shultz LD; Yamazaki H
    Endocrinology; 2004 Jun; 145(6):2721-9. PubMed ID: 14988381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of RANKL/RANK and M-CSF/c-fms in root resorption lacunae in rat molar by heavy orthodontic force.
    Nakano Y; Yamaguchi M; Fujita S; Asano M; Saito K; Kasai K
    Eur J Orthod; 2011 Aug; 33(4):335-43. PubMed ID: 20833686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific targeting of PKCδ suppresses osteoclast differentiation by accelerating proteolysis of membrane-bound macrophage colony-stimulating factor receptor.
    Kim MY; Lee K; Shin HI; Jeong D
    Sci Rep; 2019 May; 9(1):7044. PubMed ID: 31065073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.